Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Influence of OPRM1 Asn40Asp variant (A118G) on [11C]carfentanil binding potential: preliminary findings in human subjects.

Weerts EM, McCaul ME, Kuwabara H, Yang X, Xu X, Dannals RF, Frost JJ, Wong DF, Wand GS.

Int J Neuropsychopharmacol. 2013 Feb;16(1):47-53. doi: 10.1017/S146114571200017X. Epub 2012 Mar 8.

PMID:
22397905
2.

Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis.

Arias A, Feinn R, Kranzler HR.

Drug Alcohol Depend. 2006 Jul 27;83(3):262-8. Epub 2006 Jan 4.

PMID:
16387451
3.

Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.

Schacht JP, Anton RF, Voronin KE, Randall PK, Li X, Henderson S, Myrick H.

Neuropsychopharmacology. 2013 Feb;38(3):414-22. doi: 10.1038/npp.2012.195. Epub 2012 Oct 3.

4.

[μ-Opioid Receptor Gene (OPRM1) Polymorphisms A118G and C17T in Alcohol Dependence: A Turkish Sample].

Gürel ŞC, Ayhan Y, Karaaslan Ç, Akel H, Karaca RÖ, Babaoğlu MÖ, Yaşar Ü, Bozkurt A, Dilbaz N, Uluğ BD, Demir B.

Turk Psikiyatri Derg. 2016 Summer;27(2):0. Turkish.

5.
6.

Regional brain [(11)C]carfentanil binding following tobacco smoking.

Domino EF, Hirasawa-Fujita M, Ni L, Guthrie SK, Zubieta JK.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jun 3;59:100-4. doi: 10.1016/j.pnpbp.2015.01.007. Epub 2015 Jan 15.

7.

Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.

Weerts EM, Wand GS, Kuwabara H, Munro CA, Dannals RF, Hilton J, Frost JJ, McCaul ME.

Alcohol Clin Exp Res. 2011 Dec;35(12):2162-73. doi: 10.1111/j.1530-0277.2011.01565.x. Epub 2011 Jun 20.

8.

Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.

Ray R, Ruparel K, Newberg A, Wileyto EP, Loughead JW, Divgi C, Blendy JA, Logan J, Zubieta JK, Lerman C.

Proc Natl Acad Sci U S A. 2011 May 31;108(22):9268-73. doi: 10.1073/pnas.1018699108. Epub 2011 May 16.

9.

Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence.

Bencherif B, Wand GS, McCaul ME, Kim YK, Ilgin N, Dannals RF, Frost JJ.

Biol Psychiatry. 2004 Feb 1;55(3):255-62.

PMID:
14744466
10.

Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.

Nuechterlein EB, Ni L, Domino EF, Zubieta JK.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Aug 1;69:69-77. doi: 10.1016/j.pnpbp.2016.04.006. Epub 2016 Apr 17.

11.

Association study of personality factors and the Asn40Asp polymorphism at the mu-opioid receptor gene (OPRM1).

Hernandez-Avila CA, Covault J, Gelernter J, Kranzler HR.

Psychiatr Genet. 2004 Jun;14(2):89-92.

PMID:
15167694
12.

Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures.

Peciña M, Love T, Stohler CS, Goldman D, Zubieta JK.

Neuropsychopharmacology. 2015 Mar;40(4):957-65. doi: 10.1038/npp.2014.272. Epub 2014 Oct 13.

13.

Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population.

Nishizawa D, Han W, Hasegawa J, Ishida T, Numata Y, Sato T, Kawai A, Ikeda K.

Neuropsychobiology. 2006;53(3):137-41. Epub 2006 May 4.

PMID:
16679777
14.

μ-Opioid receptor gene (OPRM1) polymorphism A118G: lack of association in Finnish populations with alcohol dependence or alcohol consumption.

Rouvinen-Lagerström N, Lahti J, Alho H, Kovanen L, Aalto M, Partonen T, Silander K, Sinclair D, Räikkönen K, Eriksson JG, Palotie A, Koskinen S, Saarikoski ST.

Alcohol Alcohol. 2013 Sep-Oct;48(5):519-25. doi: 10.1093/alcalc/agt050. Epub 2013 May 30.

15.

Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects.

Weerts EM, Kim YK, Wand GS, Dannals RF, Lee JS, Frost JJ, McCaul ME.

Neuropsychopharmacology. 2008 Feb;33(3):653-65. Epub 2007 May 9.

16.

The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.

Boswell MV, Stauble ME, Loyd GE, Langman L, Ramey-Hartung B, Baumgartner RN, Tucker WW, Jortani SA.

Pain Physician. 2013 May-Jun;16(3):E227-35.

17.

Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1).

Hernandez-Avila CA, Wand G, Luo X, Gelernter J, Kranzler HR.

Am J Med Genet B Neuropsychiatr Genet. 2003 Apr 1;118B(1):60-5.

PMID:
12627468
18.

Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.

Weerts EM, Wand GS, Kuwabara H, Xu X, Frost JJ, Wong DF, McCaul ME.

Addict Biol. 2014 Jul;19(4):733-42. doi: 10.1111/adb.12022. Epub 2012 Dec 18.

19.

Naltrexone selectively elevates GABAergic neuroactive steroid levels in heavy drinkers with the Asp40 allele of the OPRM1 gene: a pilot investigation.

Ray LA, Hutchison KE, Ashenhurst JR, Morrow AL.

Alcohol Clin Exp Res. 2010 Aug;34(8):1479-87. doi: 10.1111/j.1530-0277.2010.01233.x. Epub 2010 Jun 7.

PMID:
20528823
20.

Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.

Gelernter J, Gueorguieva R, Kranzler HR, Zhang H, Cramer J, Rosenheck R, Krystal JH; VA Cooperative Study #425 Study Group.

Alcohol Clin Exp Res. 2007 Apr;31(4):555-63.

PMID:
17374034

Supplemental Content

Support Center